426 related articles for article (PubMed ID: 35573838)
41. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
Sengupta U; Kayed R
Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
[TBL] [Abstract][Full Text] [Related]
42. Alpha-synuclein spreading in Parkinson's disease.
Recasens A; Dehay B
Front Neuroanat; 2014; 8():159. PubMed ID: 25565982
[TBL] [Abstract][Full Text] [Related]
43. Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome.
Fornari S; Schäfer A; Kuhl E; Goriely A
J Theor Biol; 2020 Feb; 486():110102. PubMed ID: 31809717
[TBL] [Abstract][Full Text] [Related]
44. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
Annadurai N; De Sanctis JB; Hajdúch M; Das V
Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
[TBL] [Abstract][Full Text] [Related]
45. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
46. Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission.
Mohamed NV; Herrou T; Plouffe V; Piperno N; Leclerc N
Eur J Neurosci; 2013 Jun; 37(12):1939-48. PubMed ID: 23773063
[TBL] [Abstract][Full Text] [Related]
47. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
48. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
[TBL] [Abstract][Full Text] [Related]
49. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
[TBL] [Abstract][Full Text] [Related]
50. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
51. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
52. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
Nonaka T
Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
[TBL] [Abstract][Full Text] [Related]
53. Prion-like spread of protein aggregates in neurodegeneration.
Polymenidou M; Cleveland DW
J Exp Med; 2012 May; 209(5):889-93. PubMed ID: 22566400
[TBL] [Abstract][Full Text] [Related]
54. Role of the Lipid Membrane and Membrane Proteins in Tau Pathology.
Bok E; Leem E; Lee BR; Lee JM; Yoo CJ; Lee EM; Kim J
Front Cell Dev Biol; 2021; 9():653815. PubMed ID: 33996814
[TBL] [Abstract][Full Text] [Related]
55. Co-occurrence of mixed proteinopathies in late-stage Huntington's disease.
St-Amour I; Turgeon A; Goupil C; Planel E; Hébert SS
Acta Neuropathol; 2018 Feb; 135(2):249-265. PubMed ID: 29134321
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
57. Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease.
Uddin MS; Al Mamun A; Rahman MA; Behl T; Perveen A; Hafeez A; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
Curr Top Med Chem; 2020; 20(26):2380-2390. PubMed ID: 32479244
[TBL] [Abstract][Full Text] [Related]
58. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
Lee SJ; Lim HS; Masliah E; Lee HJ
Neurosci Res; 2011 Aug; 70(4):339-48. PubMed ID: 21624403
[TBL] [Abstract][Full Text] [Related]
59. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
60. Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.
Duyckaerts C; Seilhean D; Sazdovitch V; Plu I; Delatour B; Potier MC
Bull Acad Natl Med; 2015 Jun; 199(6):809-819. PubMed ID: 29901881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
